Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML
Conditions
Acute Myeloid Leukemia · FLT3 Internal Tandem Duplication Positive · Intermediate Risk Acute Myeloid Leukemia · Fit Patients
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China